Welcome to the public view of the “Vitamin C” grant, properly known as “Exploiting Redox Metabolism Using Pharmacological Ascorbate for Cancer Therapy.”
This five-year study consolidates ascorbate research progress carried out the University of Iowa and other institutions into a single funding mechanism with three distinct Projects: 1) pancreatic ductal adenocarcinoma, (PDAC), 2) non-small cell lung cancer (NSCLC), and 3) glioblastoma multiforme (GBM).
